Lungs News and Research

RSS

UCLA study uncovers biological clock that may shed light on why our bodies age

Everyone grows older, but scientists don't really understand why. Now a UCLA study has uncovered a biological clock embedded in our genomes that may shed light on why our bodies age and how we can slow the process.

21 Oct 2013

COPD investigational treatments: an interview with Dr. Tunde Otulana, Senior Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

Olodaterol is a long-acting beta2-agonist (LABA) bronchodilator delivered via the Respimat® inhaler. It is being investigated as a once daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

21 Oct 2013

New investigational drug offers potential treatment option for lung cancer

PF-06463922, an investigational drug being developed by Pfizer Inc., has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities in the ALK gene, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

21 Oct 2013

New research identifies internal timepiece that accurately gauge age of human organs and tissues

21 Oct 2013

Whitehead Institute scientists discover insidious nature of influenza virus

Revealing influenza's truly insidious nature, Whitehead Institute scientists have discovered that the virus is able to infect its host by first killing off the cells of the immune system that are actually best equipped to neutralize the virus.

21 Oct 2013

New prognostic tool forecasts survival of patients with advanced prostate cancer

For men with advanced prostate cancer that has progressed after taking hormones and undergoing chemotherapy, getting an accurate prognosis is critical to determine the next steps for treatment.

19 Oct 2013

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

The U.S. Food and Drug Administration today approved Opsumit (macitentan), a new drug to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive and debilitating disease that can lead to death or the need for lung transplantation.

19 Oct 2013

FEV1 poor mortality predictor in elderly

Research shows that forced expiratory volume in 1 second % predicted is ineffective for predicting mortality in elderly asthma patients.

18 Oct 2013

Blood-Based Protein Test May Distinguish Between Malignant And Benign Lung Nodules

...

17 Oct 2013

RAND Corporation study shows cost-effective way to potentially improve community's health

Modest increases in marketing and outreach to local communities can increase the amount of physical activity that occurs in parks, providing a cost-effective way to potentially improve a community's health, according to a new RAND Corporation study.

17 Oct 2013

Researchers develop new microfluidic device that could speed monitoring of bacterial infections

There are good bacteria and there are bad bacteria -- and sometimes both coexist within the same species. Take, for instance, Pseudomonas aeruginosa, a microbe common in soil and water.

17 Oct 2013

Nintedanib drug to treat NSCLC is submitted for approval from European Medicines Agency

Boehringer Ingelheim announced the submission of a Marketing Authorisation Application to the European Medicines Agency for the approval of its oral triple angiokinase inhibitor nintedanib, in combination with docetaxel, for the treatment of patients with locally advanced, metastatic or recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first line chemotherapy.

17 Oct 2013

Spraying plant hormone on broccoli may boost cancer-fighting potential

Spraying a plant hormone on broccoli - already one of the planet's most nutritious foods - boosts its cancer-fighting potential, and researchers say they have new insights on how that works.

17 Oct 2013

Scientists identify 127 mutated genes that appear to drive development of tumors in the body

Examining 12 major types of cancer, scientists at Washington University School of Medicine in St. Louis have identified 127 repeatedly mutated genes that appear to drive the development and progression of a range of tumors in the body. The discovery sets the stage for devising new diagnostic tools and more personalized cancer treatments.

17 Oct 2013

Simple urine test uses nanotechnology to detect dangerous blood clotting

Life-threatening blood clots can form in anyone who sits on a plane for a long time, is confined to bed while recovering from surgery, or takes certain medications.

17 Oct 2013

Detroit Lions, Josephine Ford Cancer Institute to raise $15M for cancer research in metro Detroit

The Detroit Lions and Josephine Ford Cancer Institute, Michigan's largest provider of adult cancer care, have created a unique partnership with the goal to raise $15 million during the next three years for cancer research in metro Detroit.

16 Oct 2013

Trovagene launches pharmaceutical alliance to monitor lung cancer patients' EGFR mutational status

Trovagene, Inc., a developer of cell-free molecular diagnostics, today announced that it will collaborate with a pharmaceutical company to evaluate Trovagene's proprietary, urine-based, cell-free DNA technology for the detection of certain epidermal growth factor receptor mutations associated with lung cancer.

16 Oct 2013

Lungs News and Research

UCLA study uncovers biological clock that may shed light on why our bodies age

COPD investigational treatments: an interview with Dr. Tunde Otulana, Senior Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

New investigational drug offers potential treatment option for lung cancer

New research identifies internal timepiece that accurately gauge age of human organs and tissues

Whitehead Institute scientists discover insidious nature of influenza virus

New prognostic tool forecasts survival of patients with advanced prostate cancer

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

FEV1 poor mortality predictor in elderly

Blood-Based Protein Test May Distinguish Between Malignant And Benign Lung Nodules

RAND Corporation study shows cost-effective way to potentially improve community's health

Researchers develop new microfluidic device that could speed monitoring of bacterial infections

Nintedanib drug to treat NSCLC is submitted for approval from European Medicines Agency

Spraying plant hormone on broccoli may boost cancer-fighting potential

Scientists identify 127 mutated genes that appear to drive development of tumors in the body

Simple urine test uses nanotechnology to detect dangerous blood clotting

Detroit Lions, Josephine Ford Cancer Institute to raise $15M for cancer research in metro Detroit

Trovagene launches pharmaceutical alliance to monitor lung cancer patients' EGFR mutational status

Ticagrelor drug may reduce risk of dying following heart attack

New type of antibiotic kills multidrug-resistant germ common to health care settings

Seven promising scientists named 2013 NYSCF - Robertson Investigators

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News